bleomycetin has been researched along with transforming growth factor beta in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, B; Li, H; Que, C; Weng, B | 1 |
| Fujitaka, K; Hamada, H; Hattori, N; Iwamoto, H; Kohno, N; Masuda, T; Nakashima, T; Omori, K; Senoo, T; Takayama, Y | 1 |
| Chen, G; Ren, JG; Sun, YF; Xia, HF; Yu, ZL; Zhang, W; Zhao, YF; Zhu, JY | 1 |
3 other study(ies) available for bleomycetin and transforming growth factor beta
| Article | Year |
|---|---|
Expression of TGF-beta 1, PDGF and IGF-1 mRNA in lung of bleomycin-A5-induced pulmonary fibrosis in rats.
Topics: Animals; Bleomycin; Insulin-Like Growth Factor I; Lung; Male; Platelet-Derived Growth Factor; Pulmonary Fibrosis; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta | 1996 |
Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts.
Topics: Aged; Animals; Benzoxazoles; Bleomycin; Cell Differentiation; Cell Line; Dicarboxylic Acids; Epithelial-Mesenchymal Transition; Female; Fibroblasts; Humans; Male; Mice; Mice, Inbred C57BL; Middle Aged; Myofibroblasts; Plasminogen Activator Inhibitor 1; Pulmonary Alveoli; Pulmonary Fibrosis; Transforming Growth Factor beta | 2016 |
Downregulation of miR-145 in venous malformations: Its association with disorganized vessels and sclerotherapy.
Topics: Bleomycin; Down-Regulation; Human Umbilical Vein Endothelial Cells; Humans; MicroRNAs; Sclerotherapy; Skin; Transforming Growth Factor beta; Vascular Malformations; Veins | 2017 |